Delivery Order SPE2DB24D9211-SPE2DB25FBNNU

Award Date 10/23/24
Potential Completion Date 11/14/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $35,734.50 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,564,068,971 Nexplanon 68 mg contraceptive implants. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, that DMS Pharmaceutical Group holds with DLA, valued at up to $4,999,999 through the end of 2025. The IDV enables...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $5,033.44 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4,557,298,149 units of the Nexplanon 68 mg implant, a contraceptive device. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which covers a wide range of branded and generic...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,573.45 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4,565,282,597 units of the Nexplanon 68 mg implant, a contraceptive device. This delivery order is part of a larger indefinite delivery contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which covers a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,858.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4,566,777,090 units of the contraceptive implant Nexplanon. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to procure a wide range of pharmaceutical products,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $10,414.65 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of 4,566,904,770 units of NEXPLANON 68 MG implants, a contraceptive device, with a period of performance through January 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group valued at $499,999,999, which allows...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $16,409.76, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,561,970,708 units of the Nexplanon 68 mg implant, a branded contraceptive device, to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC), valued at up to...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,288.14 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,815,725 units of the contraceptive implant Nexplanon 68 mg by January 14, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $25,167.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,557,562,613 units of the NEXPLANON 68 MG implants, a contraceptive device. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999, which enables the DLA to issue firm fixed-price orders for a comprehensive...
The Defense Logistics Agency (DLA) awarded a $15,434.75 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,558,920,695 units of the NEXPLANON 68 MG IMPLANTS, a prescription contraceptive device, with a completion date of October 14, 2022. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,367.48, is for the delivery of 4,562,996,888 Nexplanon 68 MG implants, with a completion date of December 8, 2023. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the...
  • SPE2DB24D9211
    Indefinite Delivery Contract
  • SPE2DB24D9211-SPE2DB25FBNNU
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,858.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,566,209,926 units of Nexplanon 68 mg implants, a contraceptive device, with a period of performance through November 14, 2024.

DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. This latest delivery order is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure the award.

Generated 1/22/25, 9:19 AM